AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
Exploration of the rationale behind avoiding systemic pulmonary vasodilators in patients with pulmonary hypertension associated with COPD, highlighting the complexities of patient management and reasons contrary to initial assumptions.